Bench to Bedside: Principles and Practice of Epoprostenol Therapy, from Maximizing Benefit to Minimizing Side Effects
Keyword(s):
Ivan Robbins, MD, Director, Pulmonary Hypertension Center, Vanderbilt University, Nashville, Tennessee, conducted this discussion. The panel included David Langleben, MD, Director, Center for Pulmonary Vascular Disease, Jewish General Hospital, McGill University, Montreal, Quebec, Canada; Michael McGoon, MD, Consultant in Cardiology, Mayo Clinic, Rochester, Minnesota; and Abby Krichman, RRT, Pulmonary Hypertension Coordinator, Duke University Medical Center, Durham, North Carolina.
2006 ◽
Vol 5
(4)
◽
pp. 32-39
◽
Keyword(s):
1988 ◽
Vol 20
◽
pp. 23